Privacy Policy
Signals Blog

Contributors

Categories

The waiting game: First human iPSC clinical trial on hold

. Nicole Forgione is a post-doctoral fellow working in the Fehlings group at the Toronto Western Research Institute. Currently she holds a Toronto Western Research Institute Fellowship to support her work on cell-based regenerative therapies for traumatic spinal cord...

Right Turn: This is not a One Direction concert review

. Last night, I took my daughters to a One Direction concert. Regardless of what you might now think of me (us), they still have several (million) fans around the world. The 40,000 screaming girls in attendance at the Rogers Centre showed the Brit boys lots of love....

Right Turn: George Daley on The Stem Cell Podcast

. Do you listen to The Stem Cell Podcast? If not, why not? Last September, former Signals co-editor Lisa Willemse blogged about the podcast, which, at the time, was celebrating its first anniversary. The hosts and creators behind the podcast are celebrating another...

Right Turn: Scaling up blood stem cells for transplants

. Cord blood banking is a growing market in North America and globally. Between 2005 and 2013, the number of privately banked units grew steadily at a CAGR (compound annual growth rate) of 25 per cent, giving companies the ability to capitalize on a part of the...

Update from the Clinic: May

. Welcome to your Update from the Clinic for the month of May. StemCells announced positive topline results from a Phase I/II study in spinal cord injury. Kite Pharma treated its first patient in a Phase I/II study investigating an anti-CD19 CAR T construct in...